Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy

Photothermal therapy (PTT) using a near-infrared (NIR) heptamethine cyanine fluorophore has emerged as an alternative strategy for targeted cancer therapy. NIR fluorophores showing a high molar extinction coefficient and low fluorescence quantum yield have considerable potential applications in phot...

Full description

Bibliographic Details
Main Authors: Sungsu Lee, Jin Seok Jung, Gayoung Jo, Dae Hyeok Yang, Yang Seok Koh, Hoon Hyun
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/9/1286
_version_ 1797711514110525440
author Sungsu Lee
Jin Seok Jung
Gayoung Jo
Dae Hyeok Yang
Yang Seok Koh
Hoon Hyun
author_facet Sungsu Lee
Jin Seok Jung
Gayoung Jo
Dae Hyeok Yang
Yang Seok Koh
Hoon Hyun
author_sort Sungsu Lee
collection DOAJ
description Photothermal therapy (PTT) using a near-infrared (NIR) heptamethine cyanine fluorophore has emerged as an alternative strategy for targeted cancer therapy. NIR fluorophores showing a high molar extinction coefficient and low fluorescence quantum yield have considerable potential applications in photothermal cancer therapy. In this study, a bifunctional sorbitol&#8722;ZW800 conjugate was used as an advanced concept of photothermal therapeutic agents for in vivo cancer imaging and therapy owing to the high tumor targetability of the sorbitol moiety and excellent photothermal property of NIR heptamethine cyanine fluorophore. The sorbitol&#8722;ZW800 showed an excellent photothermal effect increased by 58.7 &#176;C after NIR laser irradiation (1.1 W/cm<sup>2</sup>) for 5 min. The HT-29 tumors targeted by sorbitol&#8722;ZW800 showed a significant decrease in tumor volumes for 7 days after photothermal treatment. Therefore, combining the bifunctional sorbitol&#8722;ZW800 conjugate and NIR laser irradiation is an alternative way for targeted cancer therapy, and this approach holds great promise as a safe and highly efficient NIR photothermal agent for future clinical applications.
first_indexed 2024-03-12T07:08:09Z
format Article
id doaj.art-704f930fe7214e96a2c25d7af4c12926
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T07:08:09Z
publishDate 2019-09-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-704f930fe7214e96a2c25d7af4c129262023-09-02T23:17:18ZengMDPI AGCancers2072-66942019-09-01119128610.3390/cancers11091286cancers11091286Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer TherapySungsu Lee0Jin Seok Jung1Gayoung Jo2Dae Hyeok Yang3Yang Seok Koh4Hoon Hyun5Department of Otolaryngology-Head and Neck Surgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun 58128, KoreaDepartment of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, KoreaDepartment of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, KoreaInstitute of Cell and Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul 06591, KoreaDepartment of Surgery, Chonnam National University Hwasun Hospital and Medical School, Hwasun 58128, KoreaDepartment of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, KoreaPhotothermal therapy (PTT) using a near-infrared (NIR) heptamethine cyanine fluorophore has emerged as an alternative strategy for targeted cancer therapy. NIR fluorophores showing a high molar extinction coefficient and low fluorescence quantum yield have considerable potential applications in photothermal cancer therapy. In this study, a bifunctional sorbitol&#8722;ZW800 conjugate was used as an advanced concept of photothermal therapeutic agents for in vivo cancer imaging and therapy owing to the high tumor targetability of the sorbitol moiety and excellent photothermal property of NIR heptamethine cyanine fluorophore. The sorbitol&#8722;ZW800 showed an excellent photothermal effect increased by 58.7 &#176;C after NIR laser irradiation (1.1 W/cm<sup>2</sup>) for 5 min. The HT-29 tumors targeted by sorbitol&#8722;ZW800 showed a significant decrease in tumor volumes for 7 days after photothermal treatment. Therefore, combining the bifunctional sorbitol&#8722;ZW800 conjugate and NIR laser irradiation is an alternative way for targeted cancer therapy, and this approach holds great promise as a safe and highly efficient NIR photothermal agent for future clinical applications.https://www.mdpi.com/2072-6694/11/9/1286photothermal therapynear-infrared fluorescence imagingtumor targetingsorbitolZW800-1
spellingShingle Sungsu Lee
Jin Seok Jung
Gayoung Jo
Dae Hyeok Yang
Yang Seok Koh
Hoon Hyun
Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy
Cancers
photothermal therapy
near-infrared fluorescence imaging
tumor targeting
sorbitol
ZW800-1
title Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy
title_full Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy
title_fullStr Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy
title_full_unstemmed Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy
title_short Near-Infrared Fluorescent Sorbitol Probe for Targeted Photothermal Cancer Therapy
title_sort near infrared fluorescent sorbitol probe for targeted photothermal cancer therapy
topic photothermal therapy
near-infrared fluorescence imaging
tumor targeting
sorbitol
ZW800-1
url https://www.mdpi.com/2072-6694/11/9/1286
work_keys_str_mv AT sungsulee nearinfraredfluorescentsorbitolprobefortargetedphotothermalcancertherapy
AT jinseokjung nearinfraredfluorescentsorbitolprobefortargetedphotothermalcancertherapy
AT gayoungjo nearinfraredfluorescentsorbitolprobefortargetedphotothermalcancertherapy
AT daehyeokyang nearinfraredfluorescentsorbitolprobefortargetedphotothermalcancertherapy
AT yangseokkoh nearinfraredfluorescentsorbitolprobefortargetedphotothermalcancertherapy
AT hoonhyun nearinfraredfluorescentsorbitolprobefortargetedphotothermalcancertherapy